Edition:
India

Kazia Therapeutics Ltd (NVGN.OQ)

NVGN.OQ on NASDAQ Stock Exchange Capital Market

3.03USD
17 Nov 2017
Change (% chg)

-- (--)
Prev Close
$3.03
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,541
52-wk High
$7.56
52-wk Low
$2.44

Select another date:

Mon, Nov 13 2017

BRIEF-Novogen ‍enters into deal to license & assign preclinical assets

* ‍Entered into agreement to license & assign certain preclinical assets to Heaton-Brown Life Sciences​

BRIEF-Novogen ‍enteres letter of intent with Cedrus Investments Ltd

* ‍Entered into a letter of intent with Cedrus Investments Ltd for advisory services​ Source text for Eikon: Further company coverage:

BRIEF-Novogen posts FY loss of $10.7 mln

* Novogen reported FY loss of $10.7 million versus loss of $12.1 million last year

BRIEF-Novogen Ltd provides update to investors on a review of business operations

* Novogen Ltd - provide an update to investors on a review of business operations recently completed by board and management team

BRIEF-Novogen says chairman John O'connor to step down

* Chairman, john o'connor and non-executive director, ian phillips step down from novogen board

Select another date: